Ovarian cancer and body size

Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies

V. Beral, C. Hermon, R. Peto, G. Reeves, L. Brinton, P. Marchbanks, E. Negri, R. Ness, P. H M Peeters, M. Vessey, E. E. Calle, S. M. Gapstur, A. V. Patel, L. Dal Maso, R. Talamini, A. Chetrit, G. Hirsh-Yechezkel, F. Lubin, S. Sadetzki, N. Allen & 126 others V. Beral, D. Bull, K. Callaghan, B. Crossley, K. Gaitskell, A. Goodill, J. Green, C. Hermon, T. Key, K. Moser, G. Reeves, R. Collins, R. Doll, R. Peto, C. A. Gonzalez, N. Lee, P. Marchbanks, H. W. Ory, H. B. Peterson, P. A. Wingo, N. Martin, T. Pardthaisong, S. Silpisornkosol, C. Theetranont, B. Boosiri, S. Chutivongse, P. Jimakorn, Thomas E. Rohan, C. Wongsrichanalai, A. Tjonneland, L. Titus-Ernstoff, T. Byers, T. Rohan, B. J. Mosgaard, M. Vessey, D. Yeates, J. L. Freudenheim, J. Chang-Claude, R. Kaaks, K. E. Anderson, A. Folsom, K. Robien, M. A. Rossing, D. B. Thomas, N. S. Weiss, E. Riboli, F. Clavel-Chapelon, D. Cramer, S. E. Hankinson, S. S. Tworoger, S. Franceschi, C. La Vecchia, E. Negri, C. Magnusson, T. Riman, E. Weiderpass, A. Wolk, L. J. Schouten, P. A. Van den Brandt, N. Chantarakul, S. Koetsawang, D. Rachawat, D. Palli, A. Black, A. Berrington de Gonzalez, L. A. Brinton, D. M. Freedman, P. Hartge, A. W. Hsing, J. V. Lacey, R. N. Hoover, C. Schairer, S. Graff-Iversen, R. Selmer, C. J. Bain, A. C. Green, D. M. Purdie, V. Siskind, P. M. Webb, S. E. Mccann, P. Hannaford, C. Kay, C. W. Binns, A. H. Lee, M. Zhang, R. B. Ness, P. Nasca, P. F. Coogan, J. R. Palmer, L. Rosenberg, J. Kelsey, R. Paffenbarger, A. Whittemore, K. Katsouyanni, A. Trichopoulou, D. Trichopoulos, A. Tzonou, A. Dabancens, L. Martinez, R. Molina, O. Salas, M. T. Goodman, G. Lurie, M. E. Carney, L. R. Wilkens, L. Hartman, J. Manjer, H. Olsson, J. A. Grisso, M. Morgan, J. E. Wheeler, P. H M Peeters, J. Casagrande, M. C. Pike, R. K. Ross, A. H. Wu, A. B. Miller, M. Kumle, E. Lund, L. Mcgowan, X. O. Shu, W. Zheng, T. M M Farley, S. Holck, O. Meirik, H. A. Risch

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Background: Only about half the studies that have collected information on the relevance of women's height and body mass index to their risk of developing ovarian cancer have published their results, and findings are inconsistent. Here, we bring together the worldwide evidence, published and unpublished, and describe these relationships. Methods and Findings: Individual data on 25,157 women with ovarian cancer and 81,311 women without ovarian cancer from 47 epidemiological studies were collected, checked, and analysed centrally. Adjusted relative risks of ovarian cancer were calculated, by height and by body mass index. Ovarian cancer risk increased significantly with height and with body mass index, except in studies using hospital controls. For other study designs, the relative risk of ovarian cancer per 5 cm increase in height was 1.07 (95% confidence interval [CI], 1.05-1.09; p<0.001); this relationship did not vary significantly by women's age, year of birth, education, age at menarche, parity, menopausal status, smoking, alcohol consumption, having had a hysterectomy, having first degree relatives with ovarian or breast cancer, use of oral contraceptives, or use of menopausal hormone therapy. For body mass index, there was significant heterogeneity (p<0.001) in the findings between ever-users and never-users of menopausal hormone therapy, but not by the 11 other factors listed above. The relative risk for ovarian cancer per 5 kg/m2 increase in body mass index was 1.10 (95% CI, 1.07-1.13; p<0.001) in never-users and 0.95 (95% CI, 0.92-0.99; p = 0.02) in ever-users of hormone therapy. Conclusions: Ovarian cancer is associated with height and, among never-users of hormone therapy, with body mass index. In high-income countries, both height and body mass index have been increasing in birth cohorts now developing the disease. If all other relevant factors had remained constant, then these increases in height and weight would be associated with a 3% increase in ovarian cancer incidence per decade.

Original languageEnglish (US)
Article numbere1001200
JournalPLoS Medicine
Volume9
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Body Size
Ovarian Neoplasms
Meta-Analysis
Epidemiologic Studies
Body Mass Index
Hormones
Confidence Intervals
Parturition
Menarche
Mouth Neoplasms
Therapeutics
Oral Contraceptives
Parity
Hysterectomy
Alcohol Drinking
Smoking
Breast Neoplasms
Education
Weights and Measures
Incidence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ovarian cancer and body size : Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. / Beral, V.; Hermon, C.; Peto, R.; Reeves, G.; Brinton, L.; Marchbanks, P.; Negri, E.; Ness, R.; Peeters, P. H M; Vessey, M.; Calle, E. E.; Gapstur, S. M.; Patel, A. V.; Maso, L. Dal; Talamini, R.; Chetrit, A.; Hirsh-Yechezkel, G.; Lubin, F.; Sadetzki, S.; Allen, N.; Beral, V.; Bull, D.; Callaghan, K.; Crossley, B.; Gaitskell, K.; Goodill, A.; Green, J.; Hermon, C.; Key, T.; Moser, K.; Reeves, G.; Collins, R.; Doll, R.; Peto, R.; Gonzalez, C. A.; Lee, N.; Marchbanks, P.; Ory, H. W.; Peterson, H. B.; Wingo, P. A.; Martin, N.; Pardthaisong, T.; Silpisornkosol, S.; Theetranont, C.; Boosiri, B.; Chutivongse, S.; Jimakorn, P.; Rohan, Thomas E.; Wongsrichanalai, C.; Tjonneland, A.; Titus-Ernstoff, L.; Byers, T.; Rohan, T.; Mosgaard, B. J.; Vessey, M.; Yeates, D.; Freudenheim, J. L.; Chang-Claude, J.; Kaaks, R.; Anderson, K. E.; Folsom, A.; Robien, K.; Rossing, M. A.; Thomas, D. B.; Weiss, N. S.; Riboli, E.; Clavel-Chapelon, F.; Cramer, D.; Hankinson, S. E.; Tworoger, S. S.; Franceschi, S.; La Vecchia, C.; Negri, E.; Magnusson, C.; Riman, T.; Weiderpass, E.; Wolk, A.; Schouten, L. J.; Van den Brandt, P. A.; Chantarakul, N.; Koetsawang, S.; Rachawat, D.; Palli, D.; Black, A.; Berrington de Gonzalez, A.; Brinton, L. A.; Freedman, D. M.; Hartge, P.; Hsing, A. W.; Lacey, J. V.; Hoover, R. N.; Schairer, C.; Graff-Iversen, S.; Selmer, R.; Bain, C. J.; Green, A. C.; Purdie, D. M.; Siskind, V.; Webb, P. M.; Mccann, S. E.; Hannaford, P.; Kay, C.; Binns, C. W.; Lee, A. H.; Zhang, M.; Ness, R. B.; Nasca, P.; Coogan, P. F.; Palmer, J. R.; Rosenberg, L.; Kelsey, J.; Paffenbarger, R.; Whittemore, A.; Katsouyanni, K.; Trichopoulou, A.; Trichopoulos, D.; Tzonou, A.; Dabancens, A.; Martinez, L.; Molina, R.; Salas, O.; Goodman, M. T.; Lurie, G.; Carney, M. E.; Wilkens, L. R.; Hartman, L.; Manjer, J.; Olsson, H.; Grisso, J. A.; Morgan, M.; Wheeler, J. E.; Peeters, P. H M; Casagrande, J.; Pike, M. C.; Ross, R. K.; Wu, A. H.; Miller, A. B.; Kumle, M.; Lund, E.; Mcgowan, L.; Shu, X. O.; Zheng, W.; Farley, T. M M; Holck, S.; Meirik, O.; Risch, H. A.

In: PLoS Medicine, Vol. 9, No. 4, e1001200, 04.2012.

Research output: Contribution to journalArticle

Beral, V, Hermon, C, Peto, R, Reeves, G, Brinton, L, Marchbanks, P, Negri, E, Ness, R, Peeters, PHM, Vessey, M, Calle, EE, Gapstur, SM, Patel, AV, Maso, LD, Talamini, R, Chetrit, A, Hirsh-Yechezkel, G, Lubin, F, Sadetzki, S, Allen, N, Beral, V, Bull, D, Callaghan, K, Crossley, B, Gaitskell, K, Goodill, A, Green, J, Hermon, C, Key, T, Moser, K, Reeves, G, Collins, R, Doll, R, Peto, R, Gonzalez, CA, Lee, N, Marchbanks, P, Ory, HW, Peterson, HB, Wingo, PA, Martin, N, Pardthaisong, T, Silpisornkosol, S, Theetranont, C, Boosiri, B, Chutivongse, S, Jimakorn, P, Rohan, TE, Wongsrichanalai, C, Tjonneland, A, Titus-Ernstoff, L, Byers, T, Rohan, T, Mosgaard, BJ, Vessey, M, Yeates, D, Freudenheim, JL, Chang-Claude, J, Kaaks, R, Anderson, KE, Folsom, A, Robien, K, Rossing, MA, Thomas, DB, Weiss, NS, Riboli, E, Clavel-Chapelon, F, Cramer, D, Hankinson, SE, Tworoger, SS, Franceschi, S, La Vecchia, C, Negri, E, Magnusson, C, Riman, T, Weiderpass, E, Wolk, A, Schouten, LJ, Van den Brandt, PA, Chantarakul, N, Koetsawang, S, Rachawat, D, Palli, D, Black, A, Berrington de Gonzalez, A, Brinton, LA, Freedman, DM, Hartge, P, Hsing, AW, Lacey, JV, Hoover, RN, Schairer, C, Graff-Iversen, S, Selmer, R, Bain, CJ, Green, AC, Purdie, DM, Siskind, V, Webb, PM, Mccann, SE, Hannaford, P, Kay, C, Binns, CW, Lee, AH, Zhang, M, Ness, RB, Nasca, P, Coogan, PF, Palmer, JR, Rosenberg, L, Kelsey, J, Paffenbarger, R, Whittemore, A, Katsouyanni, K, Trichopoulou, A, Trichopoulos, D, Tzonou, A, Dabancens, A, Martinez, L, Molina, R, Salas, O, Goodman, MT, Lurie, G, Carney, ME, Wilkens, LR, Hartman, L, Manjer, J, Olsson, H, Grisso, JA, Morgan, M, Wheeler, JE, Peeters, PHM, Casagrande, J, Pike, MC, Ross, RK, Wu, AH, Miller, AB, Kumle, M, Lund, E, Mcgowan, L, Shu, XO, Zheng, W, Farley, TMM, Holck, S, Meirik, O & Risch, HA 2012, 'Ovarian cancer and body size: Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies', PLoS Medicine, vol. 9, no. 4, e1001200. https://doi.org/10.1371/journal.pmed.1001200
Beral, V. ; Hermon, C. ; Peto, R. ; Reeves, G. ; Brinton, L. ; Marchbanks, P. ; Negri, E. ; Ness, R. ; Peeters, P. H M ; Vessey, M. ; Calle, E. E. ; Gapstur, S. M. ; Patel, A. V. ; Maso, L. Dal ; Talamini, R. ; Chetrit, A. ; Hirsh-Yechezkel, G. ; Lubin, F. ; Sadetzki, S. ; Allen, N. ; Beral, V. ; Bull, D. ; Callaghan, K. ; Crossley, B. ; Gaitskell, K. ; Goodill, A. ; Green, J. ; Hermon, C. ; Key, T. ; Moser, K. ; Reeves, G. ; Collins, R. ; Doll, R. ; Peto, R. ; Gonzalez, C. A. ; Lee, N. ; Marchbanks, P. ; Ory, H. W. ; Peterson, H. B. ; Wingo, P. A. ; Martin, N. ; Pardthaisong, T. ; Silpisornkosol, S. ; Theetranont, C. ; Boosiri, B. ; Chutivongse, S. ; Jimakorn, P. ; Rohan, Thomas E. ; Wongsrichanalai, C. ; Tjonneland, A. ; Titus-Ernstoff, L. ; Byers, T. ; Rohan, T. ; Mosgaard, B. J. ; Vessey, M. ; Yeates, D. ; Freudenheim, J. L. ; Chang-Claude, J. ; Kaaks, R. ; Anderson, K. E. ; Folsom, A. ; Robien, K. ; Rossing, M. A. ; Thomas, D. B. ; Weiss, N. S. ; Riboli, E. ; Clavel-Chapelon, F. ; Cramer, D. ; Hankinson, S. E. ; Tworoger, S. S. ; Franceschi, S. ; La Vecchia, C. ; Negri, E. ; Magnusson, C. ; Riman, T. ; Weiderpass, E. ; Wolk, A. ; Schouten, L. J. ; Van den Brandt, P. A. ; Chantarakul, N. ; Koetsawang, S. ; Rachawat, D. ; Palli, D. ; Black, A. ; Berrington de Gonzalez, A. ; Brinton, L. A. ; Freedman, D. M. ; Hartge, P. ; Hsing, A. W. ; Lacey, J. V. ; Hoover, R. N. ; Schairer, C. ; Graff-Iversen, S. ; Selmer, R. ; Bain, C. J. ; Green, A. C. ; Purdie, D. M. ; Siskind, V. ; Webb, P. M. ; Mccann, S. E. ; Hannaford, P. ; Kay, C. ; Binns, C. W. ; Lee, A. H. ; Zhang, M. ; Ness, R. B. ; Nasca, P. ; Coogan, P. F. ; Palmer, J. R. ; Rosenberg, L. ; Kelsey, J. ; Paffenbarger, R. ; Whittemore, A. ; Katsouyanni, K. ; Trichopoulou, A. ; Trichopoulos, D. ; Tzonou, A. ; Dabancens, A. ; Martinez, L. ; Molina, R. ; Salas, O. ; Goodman, M. T. ; Lurie, G. ; Carney, M. E. ; Wilkens, L. R. ; Hartman, L. ; Manjer, J. ; Olsson, H. ; Grisso, J. A. ; Morgan, M. ; Wheeler, J. E. ; Peeters, P. H M ; Casagrande, J. ; Pike, M. C. ; Ross, R. K. ; Wu, A. H. ; Miller, A. B. ; Kumle, M. ; Lund, E. ; Mcgowan, L. ; Shu, X. O. ; Zheng, W. ; Farley, T. M M ; Holck, S. ; Meirik, O. ; Risch, H. A. / Ovarian cancer and body size : Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. In: PLoS Medicine. 2012 ; Vol. 9, No. 4.
@article{3ec7e703ffde4167a095f0edc0618479,
title = "Ovarian cancer and body size: Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies",
abstract = "Background: Only about half the studies that have collected information on the relevance of women's height and body mass index to their risk of developing ovarian cancer have published their results, and findings are inconsistent. Here, we bring together the worldwide evidence, published and unpublished, and describe these relationships. Methods and Findings: Individual data on 25,157 women with ovarian cancer and 81,311 women without ovarian cancer from 47 epidemiological studies were collected, checked, and analysed centrally. Adjusted relative risks of ovarian cancer were calculated, by height and by body mass index. Ovarian cancer risk increased significantly with height and with body mass index, except in studies using hospital controls. For other study designs, the relative risk of ovarian cancer per 5 cm increase in height was 1.07 (95{\%} confidence interval [CI], 1.05-1.09; p<0.001); this relationship did not vary significantly by women's age, year of birth, education, age at menarche, parity, menopausal status, smoking, alcohol consumption, having had a hysterectomy, having first degree relatives with ovarian or breast cancer, use of oral contraceptives, or use of menopausal hormone therapy. For body mass index, there was significant heterogeneity (p<0.001) in the findings between ever-users and never-users of menopausal hormone therapy, but not by the 11 other factors listed above. The relative risk for ovarian cancer per 5 kg/m2 increase in body mass index was 1.10 (95{\%} CI, 1.07-1.13; p<0.001) in never-users and 0.95 (95{\%} CI, 0.92-0.99; p = 0.02) in ever-users of hormone therapy. Conclusions: Ovarian cancer is associated with height and, among never-users of hormone therapy, with body mass index. In high-income countries, both height and body mass index have been increasing in birth cohorts now developing the disease. If all other relevant factors had remained constant, then these increases in height and weight would be associated with a 3{\%} increase in ovarian cancer incidence per decade.",
author = "V. Beral and C. Hermon and R. Peto and G. Reeves and L. Brinton and P. Marchbanks and E. Negri and R. Ness and Peeters, {P. H M} and M. Vessey and Calle, {E. E.} and Gapstur, {S. M.} and Patel, {A. V.} and Maso, {L. Dal} and R. Talamini and A. Chetrit and G. Hirsh-Yechezkel and F. Lubin and S. Sadetzki and N. Allen and V. Beral and D. Bull and K. Callaghan and B. Crossley and K. Gaitskell and A. Goodill and J. Green and C. Hermon and T. Key and K. Moser and G. Reeves and R. Collins and R. Doll and R. Peto and Gonzalez, {C. A.} and N. Lee and P. Marchbanks and Ory, {H. W.} and Peterson, {H. B.} and Wingo, {P. A.} and N. Martin and T. Pardthaisong and S. Silpisornkosol and C. Theetranont and B. Boosiri and S. Chutivongse and P. Jimakorn and Rohan, {Thomas E.} and C. Wongsrichanalai and A. Tjonneland and L. Titus-Ernstoff and T. Byers and T. Rohan and Mosgaard, {B. J.} and M. Vessey and D. Yeates and Freudenheim, {J. L.} and J. Chang-Claude and R. Kaaks and Anderson, {K. E.} and A. Folsom and K. Robien and Rossing, {M. A.} and Thomas, {D. B.} and Weiss, {N. S.} and E. Riboli and F. Clavel-Chapelon and D. Cramer and Hankinson, {S. E.} and Tworoger, {S. S.} and S. Franceschi and {La Vecchia}, C. and E. Negri and C. Magnusson and T. Riman and E. Weiderpass and A. Wolk and Schouten, {L. J.} and {Van den Brandt}, {P. A.} and N. Chantarakul and S. Koetsawang and D. Rachawat and D. Palli and A. Black and {Berrington de Gonzalez}, A. and Brinton, {L. A.} and Freedman, {D. M.} and P. Hartge and Hsing, {A. W.} and Lacey, {J. V.} and Hoover, {R. N.} and C. Schairer and S. Graff-Iversen and R. Selmer and Bain, {C. J.} and Green, {A. C.} and Purdie, {D. M.} and V. Siskind and Webb, {P. M.} and Mccann, {S. E.} and P. Hannaford and C. Kay and Binns, {C. W.} and Lee, {A. H.} and M. Zhang and Ness, {R. B.} and P. Nasca and Coogan, {P. F.} and Palmer, {J. R.} and L. Rosenberg and J. Kelsey and R. Paffenbarger and A. Whittemore and K. Katsouyanni and A. Trichopoulou and D. Trichopoulos and A. Tzonou and A. Dabancens and L. Martinez and R. Molina and O. Salas and Goodman, {M. T.} and G. Lurie and Carney, {M. E.} and Wilkens, {L. R.} and L. Hartman and J. Manjer and H. Olsson and Grisso, {J. A.} and M. Morgan and Wheeler, {J. E.} and Peeters, {P. H M} and J. Casagrande and Pike, {M. C.} and Ross, {R. K.} and Wu, {A. H.} and Miller, {A. B.} and M. Kumle and E. Lund and L. Mcgowan and Shu, {X. O.} and W. Zheng and Farley, {T. M M} and S. Holck and O. Meirik and Risch, {H. A.}",
year = "2012",
month = "4",
doi = "10.1371/journal.pmed.1001200",
language = "English (US)",
volume = "9",
journal = "Nature Methods",
issn = "1548-7091",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Ovarian cancer and body size

T2 - Individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies

AU - Beral, V.

AU - Hermon, C.

AU - Peto, R.

AU - Reeves, G.

AU - Brinton, L.

AU - Marchbanks, P.

AU - Negri, E.

AU - Ness, R.

AU - Peeters, P. H M

AU - Vessey, M.

AU - Calle, E. E.

AU - Gapstur, S. M.

AU - Patel, A. V.

AU - Maso, L. Dal

AU - Talamini, R.

AU - Chetrit, A.

AU - Hirsh-Yechezkel, G.

AU - Lubin, F.

AU - Sadetzki, S.

AU - Allen, N.

AU - Beral, V.

AU - Bull, D.

AU - Callaghan, K.

AU - Crossley, B.

AU - Gaitskell, K.

AU - Goodill, A.

AU - Green, J.

AU - Hermon, C.

AU - Key, T.

AU - Moser, K.

AU - Reeves, G.

AU - Collins, R.

AU - Doll, R.

AU - Peto, R.

AU - Gonzalez, C. A.

AU - Lee, N.

AU - Marchbanks, P.

AU - Ory, H. W.

AU - Peterson, H. B.

AU - Wingo, P. A.

AU - Martin, N.

AU - Pardthaisong, T.

AU - Silpisornkosol, S.

AU - Theetranont, C.

AU - Boosiri, B.

AU - Chutivongse, S.

AU - Jimakorn, P.

AU - Rohan, Thomas E.

AU - Wongsrichanalai, C.

AU - Tjonneland, A.

AU - Titus-Ernstoff, L.

AU - Byers, T.

AU - Rohan, T.

AU - Mosgaard, B. J.

AU - Vessey, M.

AU - Yeates, D.

AU - Freudenheim, J. L.

AU - Chang-Claude, J.

AU - Kaaks, R.

AU - Anderson, K. E.

AU - Folsom, A.

AU - Robien, K.

AU - Rossing, M. A.

AU - Thomas, D. B.

AU - Weiss, N. S.

AU - Riboli, E.

AU - Clavel-Chapelon, F.

AU - Cramer, D.

AU - Hankinson, S. E.

AU - Tworoger, S. S.

AU - Franceschi, S.

AU - La Vecchia, C.

AU - Negri, E.

AU - Magnusson, C.

AU - Riman, T.

AU - Weiderpass, E.

AU - Wolk, A.

AU - Schouten, L. J.

AU - Van den Brandt, P. A.

AU - Chantarakul, N.

AU - Koetsawang, S.

AU - Rachawat, D.

AU - Palli, D.

AU - Black, A.

AU - Berrington de Gonzalez, A.

AU - Brinton, L. A.

AU - Freedman, D. M.

AU - Hartge, P.

AU - Hsing, A. W.

AU - Lacey, J. V.

AU - Hoover, R. N.

AU - Schairer, C.

AU - Graff-Iversen, S.

AU - Selmer, R.

AU - Bain, C. J.

AU - Green, A. C.

AU - Purdie, D. M.

AU - Siskind, V.

AU - Webb, P. M.

AU - Mccann, S. E.

AU - Hannaford, P.

AU - Kay, C.

AU - Binns, C. W.

AU - Lee, A. H.

AU - Zhang, M.

AU - Ness, R. B.

AU - Nasca, P.

AU - Coogan, P. F.

AU - Palmer, J. R.

AU - Rosenberg, L.

AU - Kelsey, J.

AU - Paffenbarger, R.

AU - Whittemore, A.

AU - Katsouyanni, K.

AU - Trichopoulou, A.

AU - Trichopoulos, D.

AU - Tzonou, A.

AU - Dabancens, A.

AU - Martinez, L.

AU - Molina, R.

AU - Salas, O.

AU - Goodman, M. T.

AU - Lurie, G.

AU - Carney, M. E.

AU - Wilkens, L. R.

AU - Hartman, L.

AU - Manjer, J.

AU - Olsson, H.

AU - Grisso, J. A.

AU - Morgan, M.

AU - Wheeler, J. E.

AU - Peeters, P. H M

AU - Casagrande, J.

AU - Pike, M. C.

AU - Ross, R. K.

AU - Wu, A. H.

AU - Miller, A. B.

AU - Kumle, M.

AU - Lund, E.

AU - Mcgowan, L.

AU - Shu, X. O.

AU - Zheng, W.

AU - Farley, T. M M

AU - Holck, S.

AU - Meirik, O.

AU - Risch, H. A.

PY - 2012/4

Y1 - 2012/4

N2 - Background: Only about half the studies that have collected information on the relevance of women's height and body mass index to their risk of developing ovarian cancer have published their results, and findings are inconsistent. Here, we bring together the worldwide evidence, published and unpublished, and describe these relationships. Methods and Findings: Individual data on 25,157 women with ovarian cancer and 81,311 women without ovarian cancer from 47 epidemiological studies were collected, checked, and analysed centrally. Adjusted relative risks of ovarian cancer were calculated, by height and by body mass index. Ovarian cancer risk increased significantly with height and with body mass index, except in studies using hospital controls. For other study designs, the relative risk of ovarian cancer per 5 cm increase in height was 1.07 (95% confidence interval [CI], 1.05-1.09; p<0.001); this relationship did not vary significantly by women's age, year of birth, education, age at menarche, parity, menopausal status, smoking, alcohol consumption, having had a hysterectomy, having first degree relatives with ovarian or breast cancer, use of oral contraceptives, or use of menopausal hormone therapy. For body mass index, there was significant heterogeneity (p<0.001) in the findings between ever-users and never-users of menopausal hormone therapy, but not by the 11 other factors listed above. The relative risk for ovarian cancer per 5 kg/m2 increase in body mass index was 1.10 (95% CI, 1.07-1.13; p<0.001) in never-users and 0.95 (95% CI, 0.92-0.99; p = 0.02) in ever-users of hormone therapy. Conclusions: Ovarian cancer is associated with height and, among never-users of hormone therapy, with body mass index. In high-income countries, both height and body mass index have been increasing in birth cohorts now developing the disease. If all other relevant factors had remained constant, then these increases in height and weight would be associated with a 3% increase in ovarian cancer incidence per decade.

AB - Background: Only about half the studies that have collected information on the relevance of women's height and body mass index to their risk of developing ovarian cancer have published their results, and findings are inconsistent. Here, we bring together the worldwide evidence, published and unpublished, and describe these relationships. Methods and Findings: Individual data on 25,157 women with ovarian cancer and 81,311 women without ovarian cancer from 47 epidemiological studies were collected, checked, and analysed centrally. Adjusted relative risks of ovarian cancer were calculated, by height and by body mass index. Ovarian cancer risk increased significantly with height and with body mass index, except in studies using hospital controls. For other study designs, the relative risk of ovarian cancer per 5 cm increase in height was 1.07 (95% confidence interval [CI], 1.05-1.09; p<0.001); this relationship did not vary significantly by women's age, year of birth, education, age at menarche, parity, menopausal status, smoking, alcohol consumption, having had a hysterectomy, having first degree relatives with ovarian or breast cancer, use of oral contraceptives, or use of menopausal hormone therapy. For body mass index, there was significant heterogeneity (p<0.001) in the findings between ever-users and never-users of menopausal hormone therapy, but not by the 11 other factors listed above. The relative risk for ovarian cancer per 5 kg/m2 increase in body mass index was 1.10 (95% CI, 1.07-1.13; p<0.001) in never-users and 0.95 (95% CI, 0.92-0.99; p = 0.02) in ever-users of hormone therapy. Conclusions: Ovarian cancer is associated with height and, among never-users of hormone therapy, with body mass index. In high-income countries, both height and body mass index have been increasing in birth cohorts now developing the disease. If all other relevant factors had remained constant, then these increases in height and weight would be associated with a 3% increase in ovarian cancer incidence per decade.

UR - http://www.scopus.com/inward/record.url?scp=84860157091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860157091&partnerID=8YFLogxK

U2 - 10.1371/journal.pmed.1001200

DO - 10.1371/journal.pmed.1001200

M3 - Article

VL - 9

JO - Nature Methods

JF - Nature Methods

SN - 1548-7091

IS - 4

M1 - e1001200

ER -